Elective neck dissection for T3/T4 cN0 sinonasal squamous cell carcinoma

Head Neck. 2020 Dec;42(12):3655-3662. doi: 10.1002/hed.26418. Epub 2020 Aug 24.

Abstract

Background: In locally advanced sinonasal squamous cell carcinoma (SNSCC), management of the clinically node-negative (cN0) neck is variable and elective neck dissection (END) remains controversial.

Methods: Patients with surgically treated T3/T4 cN0 M0 SNSCC were identified using the NCDB. Overall survival (OS) was assessed by Cox proportional hazard analysis in propensity score-matched cohorts. Factors associated with END were evaluated with logistic regression.

Results: Two hundred twenty patients underwent END (19.6%). END did not correlated with OS in propensity score-matched cohorts (HR 0.971, 95% CI 0.677-1.392), a maxillary sinus tumor subgroup (HR 1.089, 95% CI 0.742-1.599), or by radiation status [radiation: (HR 0.802, 95% CI 0.584-1.102); no radiation: (HR 0.852, 95% CI 0.502-1.445)]. The occult metastasis rate in the END cohort was 12.7%.

Conclusion: END did not significantly improve OS in this study. Further information on disease-free survival is necessary to determine its role in advanced-stage SNSCC.

Keywords: anterior skull base tumor; database; elective neck dissection; overall survival; sinonasal carcinoma.

MeSH terms

  • Carcinoma, Squamous Cell* / pathology
  • Carcinoma, Squamous Cell* / surgery
  • Cohort Studies
  • Disease-Free Survival
  • Elective Surgical Procedures
  • Humans
  • Neck Dissection*
  • Neoplasm Staging
  • Retrospective Studies